Dr. Richard Lipscombe, Managing Director, Proteomics International Laboratories Lt 00:00:00
Dr. Lipscombe explains the distribution of diabetes internationally, citing that approximately 10% of Americans suffer from diabetes, with one third progressing to kidney disease. The PromarkerD will essentially form part of the diagnostic "toolkit" for pathology services in the early detection and prevention of DKD.
